MARKET

GSK

GSK

GSK PLC
NYSE
51.52
+0.25
+0.49%
After Hours: 51.50 -0.02 -0.04% 19:39 06/05 EDT
OPEN
51.42
PREV CLOSE
51.27
HIGH
51.97
LOW
51.27
VOLUME
4.05M
TURNOVER
--
52 WEEK HIGH
60.66
52 WEEK LOW
34.16
MARKET CAP
104.33B
P/E (TTM)
13.67
1D
5D
1M
3M
1Y
5Y
1D
GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial
TipRanks · 1d ago
Amgen: Time For An Upgrade? Yes, I Think So
Seeking Alpha · 1d ago
Acting FDA head vows to block political interference, Endpoint News says
TipRanks · 2d ago
Three studies used to justify U.S. vaccine policy under RFK Jr. face scrutiny: Guardian
Seeking Alpha · 2d ago
GlaxoSmithKline (GSK) Gets a Buy from Jefferies
TipRanks · 3d ago
FOCUS-GLP-1 drugs may have a beneficial effect across many types of cancer
Reuters · 3d ago
Defence Therapeutics appoints biopharma executive John Beaver to board
PUBT · 3d ago
Madrigal Pharmaceuticals Could Become The Next Vertex
Seeking Alpha · 4d ago
More
About GSK
GSK plc is a United Kingdom-based biopharma company. The Company’s segments include Commercial Operations and Research and Development. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) with antibiotics. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development. The Company also engaged in ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody. The Company also owns HS235, a potential molecule for the treatment of pulmonary hypertension (PH).

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.